Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization
Fuente:
arXiv
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Preprint |
| Publié: |
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866912238922629120 |
|---|---|
| author | Wiklund, Stig Johan Ytterstad, Magnus Miller, Frank |
| author_facet | Wiklund, Stig Johan Ytterstad, Magnus Miller, Frank |
| contents | Many pharmaceutical companies face concerns with the maintenance of desired revenue levels. Sales forecasts for the current portfolio of products and projects may indicate a decline in revenue as the marketed products approach patent expiry. To counteract the potential downturn in revenue, and to establish revenue growth, an in-flow of new projects into the development phases is required. In this article, we devise an approach with which the in-flow of new projects could be optimized, while adhering to the objectives and constraints set on revenue targets, budget limitations and strategic considerations on the composition of the company's portfolio. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2502_09527 |
| institution | arXiv |
| publishDate | 2025 |
| record_format | arxiv |
| spellingShingle | Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization Wiklund, Stig Johan Ytterstad, Magnus Miller, Frank Applications Many pharmaceutical companies face concerns with the maintenance of desired revenue levels. Sales forecasts for the current portfolio of products and projects may indicate a decline in revenue as the marketed products approach patent expiry. To counteract the potential downturn in revenue, and to establish revenue growth, an in-flow of new projects into the development phases is required. In this article, we devise an approach with which the in-flow of new projects could be optimized, while adhering to the objectives and constraints set on revenue targets, budget limitations and strategic considerations on the composition of the company's portfolio. |
| title | Project portfolio planning in the pharmaceutical industry -- strategic objectives and quantitative optimization |
| topic | Applications |
| url | https://arxiv.org/abs/2502.09527 |